Salivary omentin-1 following non-surgical periodontal therapy: Chronic periodontitis and type 2 diabetes mellitus
Bioinformation · 31.10.2026 · 22 (10) · 7401-7404
DOI: 10.6026/973206300227401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Priyanka Yadav.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Chronic periodontitis (CP) and type 2 diabetes mellitus (T2DM) exhibit a bidirectional inflammatory relationship, but the utility of salivary omentin-1 as a biomarker linking these conditions remains inadequately defined. Therefore, it is of interest to evaluate the salivary and serum omentin-1 levels in patients with CP with and without T2DM and assessed their changes following non-surgical periodontal therapy (NSPT). A prospective interventional study included 100 participants (35-50 years) allocated into four groups (n=25 each): CP+T2DM, CP only, healthy+T2DM and healthy controls, with omentin-1 quantified by ELISA at baseline and 3 months after NSPT. Thus, salivary omentin-1 is a promising non-invasive biomarker for monitoring periodontal inflammation and metabolic dysregulation, supporting its potential use for evaluating therapeutic response after NSPT.
Zitieren
APA
Yadav, P. (2026). Salivary omentin-1 following non-surgical periodontal therapy: Chronic periodontitis and type 2 diabetes mellitus. Bioinformation, 22(10), 7401-7404. https://doi.org/10.6026/973206300227401
Vancouver
Yadav P. Salivary omentin-1 following non-surgical periodontal therapy: Chronic periodontitis and type 2 diabetes mellitus. Bioinformation. 2026;22(10):7401-7404. doi:10.6026/973206300227401
BibTeX
@article{Yadav2026,
author = {Yadav, Priyanka},
title = {Salivary omentin-1 following non-surgical periodontal therapy: Chronic periodontitis and type 2 diabetes mellitus},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7401--7404},
doi = {10.6026/973206300227401}
}
EUVIMED